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Abstract: Tissue engineering involves using the principles of biology, chemistry and engineering to design a ‘neotissue’ 
that augments a malfunctioning in vivo tissue. The main requirements for functional engineered tissue include reparative 
cellular components that proliferate on a biocompatible scaffold grown within a bioreactor that provides specific 
biochemical and physical signals to regulate cell differentiation and tissue assembly. We discuss the role of bioreactors in 
tissue engineering and evaluate the principles of bioreactor design. We evaluate the methods of cell stimulation and 
review the bioreactors in common use today. 
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  Cells of the haematopoeitic system, musculoskeletal 
tissues and visceral organs can malfunction either due to 
developmental disorders, degeneration or trauma. A number 
of conservative, medical or surgical techniques may be 
employed to enhance the natural regeneration of these tissues 
but all of these techniques have limitations and do not 
necessarily ensure the regeneration of tissue with the 
biochemical and biomechanical properties of the native 
tissue. 
 Tissue engineering theoretically overcomes the 
limitations of these traditional curing techniques by repairing 
or replacing damaged tissue with a de novo tissue that 
resembles the native tissue. The basic principle involves the 
harvesting of cells with the potential to proliferate and 
differentiate into the desired tissue, and implanting them into 
an appropriate scaffold which provides mechanical stability 
and a template for the organizing tissue [1, 2]. A bioreactor 
then applies any combination of chemical, mechanical, 
electrical or magnetic stimulation to enhance mass transfer 
and nutrient transport within the seeded cells and to facilitate 
the correct development of the tissue [3]. Bioreactors can 
theoretically be used to support the expansion of diseased 
cells such as those of the haematopoietic system, the growth 
of three dimensional tissues such as bone and cartilage prior 
to implantation, and as an organ support device prior to 
organ transplantation [4] 
  In this article we discuss the important principles of 
bioreactor design and discuss the stimulation techniques 
employed by bioreactors in the augmentation of neotissues. 
We describe commonly used bioreactors and evaluate their 
effectiveness. 
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ASPECTS OF BIOREACTOR DESIGN 
  A number of basic design principles need to be fulfilled 
for a successful bioreactor to function [5] and these are 
discussed below. 
  First and foremost a bioreactor should allow the precise 
control of the physiological environment of the culture. This 
means controlling the temperature, oxygen concentrations, 
pH values, nutrients, media flow rate, metabolite 
concentrations and specific tissue markers within close 
limits. Tissue culture is a continuous, non steady state 
process and the cultivation and tissue specific parameters are 
changing with time. At the moment it is not possible to 
easily measure all of these variables ‘real-time’ and there is a 
requirement to develop sensors for ‘real-time’ measurement, 
or alternatively to remove samples for as close as possible 
‘real-time’ analysis. 
  The provision of essential nutrients and gases to the 
culture is of fundamental importance in bioreactor design 
and needs to emulate the rich and extensive vascular network 
of the human body. Porous scaffolds which allow high 
nutrient fluxes to cells have been employed in order to 
optimize the mass transfer processes. An overview of 
scaffold materials for tissue engineering is provided by Yang 
et al. [1]. 
  Bioreactors should also be able to support the culture of 
two or more cell types simultaneously when used to 
regenerate complex tissues. This usually involves first 
maintaining the various cell types under different culture 
conditions to expand cell numbers and then at appropriate 
time, switching to a common cultivation protocol in one 
bioreactor. 
  A bioreactor should also be designed to operate under 
strict aseptic conditions to prevent any influx of 
microorganisms that may contaminate the tissue. This   
necessitates pre sterilization of the equipment, preparation of 
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engineering process. The manufacturing requirements of a 
bioreactor must also be considered and designs must follow 
the appropriate manufacturing practice and quality assurance 
guidelines of the regulatory bodies in the appropriate 
locality. 
BIOREACTOR STIMULATION 
  The bioreactor uses various chemical, mechanical or 
electro-magnetic stimulation techniques to obtain de novo 
tissue with biomechanical properties comparable to the 
damaged or desired tissue. 
  Chemical stimulation techniques are employed by using 
chemicals such as growth factors, which are polypeptides 
that support various terminal phenotypes and regulate stem 
cell differentiation, and proliferation. Commonly used 
growth factors are transforming growth factor-, bone 
morphogenic proteins and fibroblast growth factors [5]. 
Mechanical stimulation techniques involve subjecting a 
scaffold to mechanical stresses resembling the in vivo 
environment. Suckosky et al. [6] have shown that applying 
mechanical stimulation by subjecting a scaffold to dynamic 
flow provides a uniform cell distribution throughout the 
three dimensional seeded construct resulting in a 
homogenous matrix deposition, whereas Altman et al. [7] 
have been able to show that direct mechanical strain applied 
on seeded silicone scaffolds induces the differentiation of 
cells into a ligament-like cell lineage in preference to bone or 
cartilage cell lineages. Electric and magnetic stimuli have 
also been used experimentally with encouraging results. In 
one trial a single application of low energy laser therapy on 
the middle cruciate ligament of a rat model significantly 
increased the collagen fibril size [8]. In another trial, an 
increase in osteoblast proliferation and alkaline phosphatase 
activity was reported when rabbit bone marrow was 
electrically stimulated [9]. 
IN VITRO BIOREACTORS 
1. Static Culture 
  Static culture bioreactors have been widely used in the 
past and involve the deposition of cells on a scaffold, 
supplied with the appropriate growth media, and cultured in 
an incubator. These bioreactors have severe limitations and 
studies have shown that static culture results in a non-
homogenous cell distribution that does not resemble the 
native tissue [10]. Furthermore the failure of static cultures 
to recreate the mechanical environment of in vivo tissue and 
to achieve mass transport of nutrients into large scaffolds 
result in the preferential growth of cells at the periphery of 
the scaffold which lack the biomechanical and histological 
properties of the native tissue [11]. 
2. Rotating Wall Vessel 
  This bioreactor was developed at NASA and consist of 
two concentric cylinders, within which lies an annular space 
containing the scaffold [12]. The outside wall is capable of 
rotating, and gravitational forces are balanced with 
centrifugal forces, establishing microgravity-like culturing 
conditions within the annular space and subjecting the 
scaffold to dynamic laminar flow [10]. Saini et al. [13] have 
shown that this technique is preferably used in cartilage 
tissue engineering as it provides a favorable hydrodynamic 
environment conductive to cartilage phenotype 
differentiation and cartilage tissue growth
.  In their 
experiment, porous poly-lactic acid constructs, seeded 
dynamically in the bioreactor using isolated bovine 
chondrocytes, were cultured for four weeks at three seeding 
densities and three different shear stresses to characterize the 
effect of chondrocyte density and hydrodynamic loading on 
construct growth. Construct seeding efficiency with 
chondrocytes was greater than 95% within 24 hours. 
Extensive chondrocyte proliferation and matrix deposition 
were achieved so that after 28 days in culture, constructs 
from bioreactors seeded at the highest cell densities 
contained up to 15 x 10
6 cells, 2 mg glycosaminoglycan, and 
3.5 mg collagen per construct and exhibited morphology 
similar to that of native cartilage. 
 Marlovits et al. [14] inoculated differentiated 
chondrocytes in a rotating wall vessel without the use of any 
scaffolding material. After 90 days of cultivation, cartilage-
like neotissue was formed, encapsulated by fibrous tissue 
that closely resembled the perichondrium. Overall the 
rotating wall vessel bioreactor has currently been shown to 
optimize nutrient transport and promote cartilage growth and 
differentiation superior to other currently tested culturing 
techniques [15]. 
3. Spinner Flask 
  In this type, cell seeded scaffolds attached to needles are 
suspended from the top cover of a flask in culture medium. 
Mixing of the medium is sustained with a magnetic stir bar 
placed at the bottom of the flask [16]. Constructs cultured in 
spinner flasks have a higher cell seeding density and more 
uniform distribution of cells when compared to a static 
culture model [17]. Vunjak-Novakovic et al. [18] have 
shown that turbulent mixing of nutrients in a spinner flask 
bioreactor significantly enhances the biochemical 
compositions and alters morphologies of engineered 
constructs. 
  The spinner flask bioreactor seems to support 
osteogenesis more than the rotating wall vessel bioreactor. 
Sikavitsas et al. [19] in their study compared the outcomes 
of rat mesenchymal stem cells cultured on polymeric 
scaffolds for a period of 21 days using static, spinner flask 
and rotating wall vessel systems. Results showed that cells 
cultured in the spinner flask had the highest alkaline 
phosphatase activity and osteocalcin secretion among the 
three culturing systems. Additionally spinner flask constructs 
had higher proliferation rate and calcium content than 
statically cultured constructs. 
4. Flow Perfusion 
  Flow perfusion bioreactors utilize a pump to percolate 
medium continuously through the scaffold’s interconnected 
pores and eliminate the internal transport limitations of the 
spinner flask and rotating wall vessel [20]. The enhanced 
nutrient transfer has been shown to result in improved mass 
transfer [16], homogeneous cell distribution and high 
seeding efficiency [11] throughout the thickness of the 
scaffold. Fluid shear forces in flow perfusion systems also 
causes mechanical stimulation of the culture and has been 
shown to enhance the expression of the osteoblastic 
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  It has also been widely reported that fluid shear enhances 
in vitro osteogenesis. In the study conducted by Gomes et al. 
[22] bone marrow derived mesenchymal stem cells were 
cultured statically and in a perfusion system. Only a surface 
layer of cells was observed for statically cultured constructs 
as opposed to a homogeneous cell distribution throughout 
the scaffold for perfused constructs. The proliferation rate 
and alkaline phosphatase activity patterns were similar for 
both types of culture techniques, while scaffolds that were 
cultured under perfused conditions showed a significant 
increase in calcium deposition. 
 Goldstein  et al. [23] used osteoblastic cells, which were 
seeded on PLGA foams and cultured for two weeks in three 
different bioreactors: rotating wall vessel, spinner flask and 
flow perfusion. Cell seeding efficiencies and osteocalcin 
content were similar for the three systems. However, the 
spinner flask produced the least uniform cell distribution 
throughout the foams and the rotating wall vessel system 
resulted in the lowest levels of alkaline phosphatase activity. 
Consequently, the flow perfusion system appears to be a 
very attractive culturing technique for bone constructs. 
IN VIVO BIOREACTORS 
  This is a bioengineering approach that depends on the 
conductive properties of the implanted scaffold to recruit 
mesenchymal stem cells from neighboring tissue and takes 
advantage of the physiological environment to supply the 
necessary growth factors and nutrients to the construct. The 
main challenge is to find the appropriate scaffolding material 
that would induce the differentiation of mesenchymal stem 
cells into an adequate lineage. Several attempts have been 
made to develop in vivo bioreactors which can generate 
vascularised host bone tissue. 
 Stevens  et al. [24] hypothesized that by inhibiting 
angiogenesis and promoting a more hypoxic environment 
within the bioreactor space, cartilage formation could be 
exclusively promoted. They incorporated an in vivo 
bioreactor, where artificial space created between the tibia 
and the periosteum using alginate gel, into the tibia of New 
Zealand white rabbits. Preosteoblastic cells were recruited 
from the inner layer of the periosteum. The engineered bone 
tissue was found to be biomechanically identical to native 
bone. When harvested and implanted into contralateral tibial 
defects, the engineered bone completely integrated within 
the native bone tissue after six weeks with no apparent 
morbidity at the donor site. 
  In the design of another in vivo bioreactor used by Holt et 
al. [25] the scaffold was composed of coralline cylinders and 
supplemented with the growth factor BMP-2. A vascular 
pedicle was incorporated into the scaffold to supply a 
channel for the mesenchymal stem cells recruited by BMP-2 
from the blood circulation into the bioreactor and silicone 
was used to isolate the bioreactor from the surrounding 
environment. This closed system ensured that bone 
formation would depend solely on the internal scaffold and 
the invading cells with osteogenic potential. The designed in 
vivo  bioreactors were implanted into 12 male rats and 
harvested after six weeks. The extracted implants 
demonstrated neovascular ingrowth and new bone formation 
of 11.3%. This unique design can be used in future tissue 
engineering applications and can potentially help in 
conditions of skeletal defects e.g. nonunion and tumor post-
resection reconstruction. It may also serve as a model in 
which to study primary and metastatic cancers of bone. 
CONCLUSION 
  Tissue Engineering is a pioneering field and bioreactors 
have an important role in creating the ideal environment for 
the generation of a particular neotissue. The principles of 
bioreactors have been defined and advances in the 
understanding of stimulation techniques and appropriate 
scaffolds will lead to these goals being met in vitro and in 
vivo. The role of growth factors in the differentiation and 
proliferation of stem cells is clear, and mechanical 
stimulation has been shown to be important especially in 
musculoskeletal tissue engineering. Early generation static 
bioreactors are associated with non-homogenous cell 
distributions and sub-optimal mechanical tissue properties, 
whereas flow perfusion and rotating wall vessels are 
associated with more efficient nutrient transport, cell 
distribution and more ideal cell and tissue characteristics. 
Despite this, there is a need to further elucidate the specific 
biochemical and biomechanical factors necessary for cell, 
tissue or organ development and to modify the designs of 
bioreactors if needed, to result in neotissues with optimal 
features for clinically successful tissue engineering. 
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